Glass Found in Lipitor Batches Halts Production

Traces of glass particles in Lipitor batches forced manufacturer Ranbaxy Pharmaceuticals Inc. to halt its production while an investigation is taking place. Upon finding the stem of the problem and determining a way to rectify it, the Food and Drug Administration will allow Ranbaxy to resume after the November Lipitor or atorvastatin recall until then, […]